Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Cytochrome P450: Drug Interactions in Psychiatry
2 posters
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Cytochrome P450: Drug Interactions in Psychiatry
Cytochrome P450: Drug Interactions in Psychiatry
Cytochrome P450 is a family of isozymes responsible for the biotransformation of several drugs.
Although a majority of the isozymes are located in the liver, extrahepatic metabolism also occurs in the kidneys, skin, gastrointestinal tract, and lungs.
Recognizing whether the drugs involved act as enzyme substrates, inducers, or inhibitors can prevent clinically significant interactions from occurring.
This thread is dedicated to Cytochrome P450 enzymes substrates, inhibitors and inducers.
INDEX:
Page 1:
• CYP450 1A2
• CYP450 2D6
• CYP450 3A4
Regards
Admin
Cytochrome P450 is a family of isozymes responsible for the biotransformation of several drugs.
Although a majority of the isozymes are located in the liver, extrahepatic metabolism also occurs in the kidneys, skin, gastrointestinal tract, and lungs.
Recognizing whether the drugs involved act as enzyme substrates, inducers, or inhibitors can prevent clinically significant interactions from occurring.
This thread is dedicated to Cytochrome P450 enzymes substrates, inhibitors and inducers.
INDEX:
Page 1:
• CYP450 1A2
• CYP450 2D6
• CYP450 3A4
Regards
Admin
Last edited by Admin on Mon Sep 10, 2012 9:33 pm; edited 3 times in total
Re: Cytochrome P450: Drug Interactions in Psychiatry
A very nice overview!
I just want to add that the list of substrates for various cyp enzymes can be quite extensive as you have shown in the images above. It is important to keep in mind that in most cases, the drugs which are substrates of ONE cyp enzyme or have a major metabolic cyp enzyme (clozapine - 1A2, olanzapine - 1A2, risperidone - 2D6) are the ones which will cause clinically significant drug-drug interactions.
This may be complicated if drugs are given with substances known as "pan-inducers" like carbamazepine or "pan-inhibitors" like fluoxatine. In that case, even drugs with multiple metabolic pathways can have clinically significant changes in serum concentrations.
I just want to add that the list of substrates for various cyp enzymes can be quite extensive as you have shown in the images above. It is important to keep in mind that in most cases, the drugs which are substrates of ONE cyp enzyme or have a major metabolic cyp enzyme (clozapine - 1A2, olanzapine - 1A2, risperidone - 2D6) are the ones which will cause clinically significant drug-drug interactions.
This may be complicated if drugs are given with substances known as "pan-inducers" like carbamazepine or "pan-inhibitors" like fluoxatine. In that case, even drugs with multiple metabolic pathways can have clinically significant changes in serum concentrations.
P450- Moderator
- Posts : 34
Points : 34
Reputation : 0
Join date : 2012-01-15
Re: Cytochrome P450: Drug Interactions in Psychiatry
P450 wrote:A very nice overview!
I just want to add that the list of substrates for various cyp enzymes can be quite extensive as you have shown in the images above. It is important to keep in mind that in most cases, the drugs which are substrates of ONE cyp enzyme or have a major metabolic cyp enzyme (clozapine - 1A2, olanzapine - 1A2, risperidone - 2D6) are the ones which will cause clinically significant drug-drug interactions.
This may be complicated if drugs are given with substances known as "pan-inducers" like carbamazepine or "pan-inhibitors" like fluoxatine. In that case, even drugs with multiple metabolic pathways can have clinically significant changes in serum concentrations.
Thanks for clarification. I was about to e-mail you with above confusion of "multiple substrates".
Similar topics
» Psychiatry: Where are we going?
» TBI & Psychiatry: Facts
» Geriatric Psychiatry
» Humor in Psychiatry :)
» PRITE High Yield Topic Discussion Thread
» TBI & Psychiatry: Facts
» Geriatric Psychiatry
» Humor in Psychiatry :)
» PRITE High Yield Topic Discussion Thread
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin